- Home
- TLSA vs JYNT Comparison
TLSA vs JYNT Comparison
Compare TLSA & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- JYNT
- Stock Information
- Founded
- TLSA 2013
- JYNT 2010
- Country
- TLSA United Kingdom
- JYNT United States
- Employees
- TLSA N/A
- JYNT N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- JYNT Multi-Sector Companies
- Sector
- TLSA Health Care
- JYNT Miscellaneous
- Exchange
- TLSA Nasdaq
- JYNT Nasdaq
- Market Cap
- TLSA 187.0M
- JYNT 170.1M
- IPO Year
- TLSA 2000
- JYNT 2014
- Fundamental
- Price
- TLSA $1.86
- JYNT $11.36
- Analyst Decision
- TLSA
- JYNT Strong Buy
- Analyst Count
- TLSA 0
- JYNT 2
- Target Price
- TLSA N/A
- JYNT $15.50
- AVG Volume (30 Days)
- TLSA 242.1K
- JYNT 59.4K
- Earning Date
- TLSA 08-05-2025
- JYNT 08-07-2025
- Dividend Yield
- TLSA N/A
- JYNT N/A
- EPS Growth
- TLSA N/A
- JYNT N/A
- EPS
- TLSA N/A
- JYNT N/A
- Revenue
- TLSA N/A
- JYNT $52,789,479.00
- Revenue This Year
- TLSA N/A
- JYNT $9.48
- Revenue Next Year
- TLSA N/A
- JYNT $11.15
- P/E Ratio
- TLSA N/A
- JYNT N/A
- Revenue Growth
- TLSA N/A
- JYNT 71.05
- 52 Week Low
- TLSA $0.63
- JYNT $9.58
- 52 Week High
- TLSA $1.91
- JYNT $14.87
- Technical
- Relative Strength Index (RSI)
- TLSA 70.48
- JYNT 48.29
- Support Level
- TLSA $1.62
- JYNT $11.30
- Resistance Level
- TLSA $1.89
- JYNT $11.78
- Average True Range (ATR)
- TLSA 0.10
- JYNT 0.35
- MACD
- TLSA 0.03
- JYNT -0.05
- Stochastic Oscillator
- TLSA 93.48
- JYNT 17.05
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.